Skip to main content
OpenTrials

Clinical trial condition

KRAS/NRAS Mutation

Explore clinical trials studying KRAS/NRAS Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

KRAS/NRAS Mutation trial results

Active, Not Recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

NCT06106308

Conditions
CRC, Colonic Diseases, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 41 locations
View Trial Details

Related conditions